VAX-24

N/A

Report date: 2023/01/06 09:53:17

Base Information

Drug NameVAX-24

Drug Alias Name24-Valent pneumococcal conjugate vaccine (Vaxcyte)VAX-24SVX-24

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccineVaccines > Vaccine type > Multivalent vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsOtitis MediaPneumonia, PneumococcalPneumococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesVaxcyte Inc

China Registration ClassN/A

Develop Information

Active CompaniesVaxcyte Inc

Inactive CompaniesN/A

Active IndicationsOtitis MediaPneumonia, PneumococcalPneumococcal Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A